Raymond James Financial Inc Cure Vac N.V. Transaction History
Raymond James Financial Inc
- $280 Billion
- Q2 2025
A detailed history of Raymond James Financial Inc transactions in Cure Vac N.V. stock. As of the latest transaction made, Raymond James Financial Inc holds 23 shares of CVAC stock, worth $125. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23Holding current value
$125% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CVAC
# of Institutions
103Shares Held
14.2MCall Options Held
270KPut Options Held
114K-
Black Rock Inc. New York, NY2.25MShares$12.3 Million0.0% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ1.97MShares$10.7 Million0.58% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.57MShares$8.55 Million10.6% of portfolio
-
Qube Research & Technologies LTD London, X01.18MShares$6.44 Million0.01% of portfolio
-
Water Island Capital LLC New York, NY957KShares$5.22 Million1.03% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $1.02B
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...